A Texas man filed a lawsuit in the Philadelphia Court of Common Pleas against Johnson & Johnson and its subsidiary, Janssen, in connection to the development of female breast tissue that he alleges was caused by Risperdal and Invega.
Of further interest:
Antipsychotic Risperdal Slapped with $2 Billion Dementia Penalty (Alzheimer’s & Dementia Weekly)
Man Files Risperdal Lawsuit Against Maker over Gynecomastia (Your Legal Help.com)
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at
Is anyone going to sue NAMI for promoting Risperdal ?
The National Alliance For The Mentally Ill was marketing Risperdal for kids, they had this link posted on the front page of there website. Its still there on the web archive.
“Risperidone for Adolescent Aggression”
Medical Focus, Winter 1996
How do they always get off the hook ?
Because they have the ear of the government and of the media. They’re also supported by drug company money, probably most of their money comes from drug companies. The shills must be paid for their services.
I don’t understand how NAMI is called Non profit and is tax exempt.
NAMI PR and Marketing Toolkit:
PR and marketing, that’s what they do.
They are still pushing/advertizing the use of anti psychotics off label in children today 2013 ! “Antipsychotic medications and mood stabilizers have been proven to be effective in treating oppositional defiant disorder and conduct disorder.”
ANTI PSYCHOTICS ARE NOT FDA APPROVED for “oppositional defiant disorder”, NAMI you pharma front